mediate pro-inflammatory reactions and help B cells Blood samples produce IgG2a, whereas Th2 type cells help B cells in Blood was taken from the HD patients before their dialysis production of antibody IgG1 and IgE [26 ] . Although session. Samples from HD, PD and controls were all taken these functionally distinct T cell subsets were originally by venipuncture. All blood was collected in heparin and described in the mouse, human T cell clones have separation of mononuclear cells from peripheral blood was subsequently been shown to have a similar, but not performed by standard techniques (Ficoll gradient). All cells identical restricted cytokine profile. Here we have were frozen in liquid nitrogen in a solution of 10% DMSO studied the cytokine profile of the T (CD3+) cells plus foetal calf 's serum (FCS; Bio Whittaker, Verviers, within the peripheral blood mononuclear cell (PBMC ) Belgium) in RPMI (Bio Whittaker, Wokingham, UK ) by population from 45 patients with end stage renal standard techniques until use. disease on chronic dialysis. To assess the effects of produce cytokines after stimulation in patients who Antibodies had been on PD compared to low flux HD and normal individuals. This is the first study which analyses the All antibodies used were fluorescence labelled, either with fluorescence isothiocyanate (FITC ) or phycoerythyene (PE).
effect of different modes of long term dialysis on T cell
Monoclonal antibodies used to detect surface antigen; anticytokine production. We chose to analyse the frequency CD3-FITC and anti-CD3-PE (T cells) were obtained from of T cells producing Th1 and Th2 cytokines using the Becton Dickinson (Palo alto, USA). Antibodies used to stain new technique of intracellular cytokine staining. Our for intracellular cytokines (and their isotype matched conresults suggest that the uraemic state inhibits T cells trols) were all obtained from Pharminogen (Cambridge from producing Th2 cytokines, moreover T cells from Biosciences, Cambridge, UK ). The anti-cytokine antibodies patients on PD but not low flux HD could not be were: anti-IL-2-PE (rat IgG2a; clone MQ1-17H12), anti-ILconsistently induced to produce IL-2 or TNFa. 
Subjects and methods
IgG2a, PE conjugated) and clone MOPC-21 (mouse IgG1, FITC or PE conjugated ). We studied 45 patients with end-stage renal disease on chronic dialysis. Twenty-five patients were on chronic HD Stimulating T cells and had never been on PD and 20 patients were on PD without having been on HD. Within the HD group there Cells were thawed in 12.5% FCS in RPMI (wash buffer) then were 16 males and 9 females. Within the PD group there washed twice in wash buffer. 1×106 cells were then placed were 14 males and 6 females. The mean age of HD and PD in 1 ml RPMI plus 10% human serum (Bio Whittaker) patients was 52.1 and 57.9 years respectively. The patients (unstimulated cells) or stimulation mixture (20 ng/ml undergoing HD had 4-h sessions three times a week. These phorbol-12-myristate-13-acetate; PMA from Sigma, 1 mM patients were dialysed using only Hemophan membranes Ionomycin; I from Calbiochem, Nottingham, UK, 3 mM (Gambro Dialysatoren, GmbH and Co, Hechingen, Monensin from Calbiochem, and 10% human serum), for Germany), there was no dialyser reuse. 4 h 37°C in 5% CO 2 . Cells were then stained for intracellular Seventeen patients in HD group and 12 patients in PD cytokines. had an initial diagnosis of chronic glomerulonephritis (biopsy proved ). Eight patients in HD group and 8 patients in PD
Intracellular cytokine staining
had an initial diagnosis of insulin-dependent diabetes mellitus and they developed end-stage renal failure due to diabetic Aliquots of 105 cells/tube were washed twice in staining nephropathy (DN ). We selected DN patients which had buffer (Dulbecco's PBS from Gibco BRL Paisley, UK; 1% stable and controlled serum glucose levels.
heat-inactivated FCS, 0.1% (w/v) sodium azide from BDH We also studied 10 healthy controls with an age range Laboratory Supplies, Poole, UK; pH 7.4-7.6). The pellet from 21 to 52, the mean age was 36.2 (4 male, 6 female) was resuspended in 30 ml staining buffer plus anti-CD3-FITC without any known disease and not taking medication. This or anti-CD3-PE. Cells were incubated for 20 min at 4°C, group was department and laboratory staff.
washed, fixed in Cell FIX (Becton Dickinson, San Jose, USA) and left for 20 min at 4°C in the dark. To permeabilize the cells they were washed twice in permeabilization buffer
Patient status
(staining buffer plus 0.1% saponin; Sigma, Poole, Dorset, UK ). Cells were then spun down and resuspended in a No patients had active infection, malignancy or an inflammatory state and none were taking immuno-suppressive previously determined optimal concentration of an anticytokine or control conjugated antibody. After incubation medication. All patients were HIV-negative and none had Hepatitis B antigen. We selected PD patients which showed at 4°C for 30 min in the dark cells were washed with permeabilization buffer. Cells were analysed within 24 h by no signs of any infection over the previous 3 months. The clinical and biochemical characteristics of the patient groups a FACScan flow cytometer after acquiring 10 000 cells (Becton Dickinson). Data was evaluated by Consort 30 are described in Table 1 . All three groups (HD, PD and control ) had white blood cell counts, total serum protein software (Becton Dickinson) and is expressed as the percentage of double stained (anti-cytokine and anti-CD3) positive and serum albumen levels within the normal range. Whereas, as expected, the haemoglobin, serum urea and serum creatin-cells in the total population. Samples were analysed by either Student's t-test or one tailed paired t-test. We assumed ine levels were only within the normal range in the control group.
significance at P<0.05. 
Results and discussion
IL-10) as expected. However, we did not see this for the low flux HD and PD groups ( Figure 2 ). We found To delineate the T cell response we set up a system to that mitogen stimulation significantly enhanced the analyse the frequency of cytokine producing T cells percentage of the classical Th1 cytokines ( IL-2, IFNc within the PBMC of our dialysis patients. A total of and TNFa) in the low flux HD PBMCs, but had no 10 000 events were acquired and analyses was perconsistent effect on CD3+ IL-2 or CD3+ TNFa produformed on a live gate selected by forward and size cing cells in the PD group. scatter characteristics ( Figure 1a ).
There are many differences between PD and low We then set quadrants around our negative conflux HD modalities, these differences range from trol (unstained PBMCs from a normal individual; differences in the dialysate [30,31] to biocompatability Figure 1b ) and used these quadrants for all further issues [32, 33] . However there are also differences in analyses. Further negative controls were the PBMCs the patients well-being and an individual on PD is stained with FITC or PE conjugated antibodies, isomore likely to have multiple infections [31] . Although type matched to the anti-cytokine antibodies plus our PD group was selected on the basis that they staining with the corresponding anti-CD3 PE or FITC showed no clinical infection for a minimum of 3 conjugate. Our positive controls were the PBMC months it is likely that they had sub-clinical infections. derived from normal individuals, stimulated with It therefore seems likely that individuals on PD will PMA+I and stained with anti-cytokine FITC or PE have chronically stimulated T cells, due to multiple antibody plus the corresponding anti-CD3 PE or FITC infections and ex vivo are exhausted. This exhaustion conjugated antibody. Figure 1b shows an example of of T cells has previously been described, for example PBMC obtained from a normal individual stained as in diabetes T cells ex vivo make little IL-2 [34] and has described above. The percentage of CD3+ cells within recently been attributed to pre-translational regulathis PBMC population was approximately 73% and tion [35] . the percentage of PBMC doubled stained with antiThus, we saw a trend, which was significant, which CD3 and anti-cytokine isotype matched control antisuggested that Th1 cells in the PBMC of patients on body was always less than 5%. The percentage of PD could not always be stimulated to produce cytocytokine producing T cells was greater than 10% with kines. This was not true for IFNc and we have two the exception of IL-10. This cytokine was difficult to explanations for this. Firstly, because CD4 expression detect in the normal individuals PBMC T cells, possibly is down modulated by PMA [36 ] we had to restrict due to the late kinetics of its detection [27] , nevertheless our analysis to CD3+ cells. We have previously shown a 4 h stimulation of PMA+I did enhance the detection that CD8+ cells produce very high levels of IFNc [37], of this cytokine significantly (P<0.05; Figure 3 ) and we therefore cannot overlook the possibility that CD8+ so we continued to analyse the frequency of T cells cells are contributing to the IFNc detected and we are producing this cytokine.
not looking at the T helper population. Thus we may In general a T cell will not produce cytokines unless have masked the Th1 IFNc response by not analysing stimulated, therefore to analyse the frequency of cells only CD4+ cells. with the potential to produce certain cytokines T cells However, a more plausible explanation may be that are generally stimulated with a mitogen in vitro [28, 29] .
the Th1 cells in the PBMC from patients on PD have Here we analysed the frequency of cytokine producing been over-stimulated in vivo. This is manifested in cells before and after PMA+I stimulation in PBMCs vitro by our observation that we cannot always derived from our three groups of individuals. In our further stimulate the cells to produce IL-2 or TNFa. control group of individuals PMA+I significantly increased the percentage of T cells expressing all the However, the cells through chronic in vivo stimulation, (a) (b) Fig. 1 . Setting up the system of analysis. Peripheral blood mononuclear cells (PBMC ) from normal individuals was either placed in 1 ml RPMI plus 10% human serum (unstimulated cells) or stimulation mixture (10 mg/ml phorbol-12-myristate-13 acetate; PMA, 1 mM Ionomycin; I and 3 mM Monensin, and 10% Human serum, for 4 h 37°C in 5% CO 2 . Cells were then stained extracellularly with anti-CD3 and intracellularly for cytokine or with a control antibody, as described in the materials and methods section. Cells were analysed within 24 h by a FACScan flow cytometer after acquiring 10 000 cells. Data was evaluated by Consort 30 software (Becton Dickinson). A total of 10 000 events were acquired and analyses was performed on a live gate selected by forward and size scatter characteristics (A). We then set quadrants around our negative controls and used these quadrants for all further analyses (B). Results are expressed as a percentage of cells stained in the total population.
Cytokine production by T cell from dialysis patients 53 are spontaneously producing IFNc when removed from the patient. This hypothesis is supported by our observation that the mean percentage of CD3+ cells producing IFNc spontaneously in the PD group (Nil stimulation) (14.5±13.0) was significantly higher by student's t-test, (P<0.005) than the control group (0.6±0.5). In addition the mean percentage of IFNc producing T cells after mitogen stimulation, was significantly higher in the PD group (22.8+13.5) compared to the control (7.1+3.0; P<0.005).
When we analysed the percentage of T cells producing the 'classical' Th2 cytokines (IL-4 and IL-10) we found a different pattern of response. Neither the percentage of T cells producing IL-4 nor IL-10 could be consistently enhanced by mitogen stimulation in either of the dialysis groups, although the control PBMC had an increase in frequency of IL-4 (P<0.05) and IL-10 (P<0.05) with PMA+I stimulation ( Figure 3 ). After cells had been removed from the patient, the mononuclear cells were separated out from the blood, washed several times and then stimulated in vitro, thus any factor acting on the T cells must have a long term effect. Since T cells from both the low flux Fig. 2 . Th1 cytokine production by cells from patients in different dialysis groups before and after stimulation. Peripheral blood mononuclear cells (PBMC ) from individuals on haemodialysis (HD), peritoneal dialysis (PD) or the control group were either placed in 1 ml RPMI plus 10% human serum (Nil ) or stimulation mixture (10 mg/ml phorbol-12-myristate-13-acetate, 1 mM Ionomycin; and 3 mM Monensin, and 10% human serum; PMA+I ), for 4 h at 37°C in 5% CO 2 . Cells were then stained extracellularly with anti-CD3 and intracellularly for cytokine, as described in the materials and methods section. Data was analysed as described for Figure 1 . Cells were analysed for their ability to produce the Th1 type cytokines (IFNc, IL-2 and TNFa). The figures represent the changes in the percentage of CD3+ cytokine producing cells in the PBMC population with PMA+I stimulation in different dialysis groups and the Fig. 3 . Th2 cytokine production by cells from patients in different control. The changes in the percentage of CD3+ P values were dialysis groups before and after stimulation. PBMC were stimulated determined by paired t-test, comparing unstimulated to PMA+I and analysed as described for ability to produce the Th2 type cytokines (IL-4 and IL-10).
